Martin Shkreli, former CEO of Turing Pharmaceuticals, leaves a U.S. Federal courthouse following an arraignment on charges of securities fraud in New York, on Dec. 17, 2015.
Andrew Gombert—EPA
January 8, 2016

Martin Shkreli is worth at least $45 million, according to newly released court filing.

According to the New York Times, a court filling disclosed by federal prosecutors Thursday shows that a brokerage account containing $45 million was used to secure the $5 million bond posted by Shkreli after his Dec. 17 arrest.

The Times says this brokerage account at E-Trade is the first public accounting of how much money Shkreli,the Turing Pharmaceuticals CEO who became infamous for raising the price of a life-saving pill from $13.50 to $750, has made.

Shkreli was arrested in December for securities fraud.

 

Write to Tessa Berenson at tessa.berenson@time.com.

Read More From TIME

EDIT POST